SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence

Detalles Bibliográficos
Autores principales: Rahman, Md. Mominur, Akash, Shopnil, Islam, Md. Rezaul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389593/
https://www.ncbi.nlm.nih.gov/pubmed/36799844
http://dx.doi.org/10.1097/JS9.0000000000000173
_version_ 1785082335889195008
author Rahman, Md. Mominur
Akash, Shopnil
Islam, Md. Rezaul
author_facet Rahman, Md. Mominur
Akash, Shopnil
Islam, Md. Rezaul
author_sort Rahman, Md. Mominur
collection PubMed
description
format Online
Article
Text
id pubmed-10389593
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-103895932023-08-01 SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence Rahman, Md. Mominur Akash, Shopnil Islam, Md. Rezaul Int J Surg Correspondence Lippincott Williams & Wilkins 2023-01-24 /pmc/articles/PMC10389593/ /pubmed/36799844 http://dx.doi.org/10.1097/JS9.0000000000000173 Text en © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Correspondence
Rahman, Md. Mominur
Akash, Shopnil
Islam, Md. Rezaul
SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title_full SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title_fullStr SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title_full_unstemmed SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title_short SARS-CoV-2 new variant BF.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
title_sort sars-cov-2 new variant bf.7: a new public threat globally, symptoms, precautions, transmission rate, and futures perspective – correspondence
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389593/
https://www.ncbi.nlm.nih.gov/pubmed/36799844
http://dx.doi.org/10.1097/JS9.0000000000000173
work_keys_str_mv AT rahmanmdmominur sarscov2newvariantbf7anewpublicthreatgloballysymptomsprecautionstransmissionrateandfuturesperspectivecorrespondence
AT akashshopnil sarscov2newvariantbf7anewpublicthreatgloballysymptomsprecautionstransmissionrateandfuturesperspectivecorrespondence
AT islammdrezaul sarscov2newvariantbf7anewpublicthreatgloballysymptomsprecautionstransmissionrateandfuturesperspectivecorrespondence

Ejemplares similares